[go: up one dir, main page]

AU2003213787A1 - Compositions and methods for the treatment of anorectal disorders - Google Patents

Compositions and methods for the treatment of anorectal disorders

Info

Publication number
AU2003213787A1
AU2003213787A1 AU2003213787A AU2003213787A AU2003213787A1 AU 2003213787 A1 AU2003213787 A1 AU 2003213787A1 AU 2003213787 A AU2003213787 A AU 2003213787A AU 2003213787 A AU2003213787 A AU 2003213787A AU 2003213787 A1 AU2003213787 A1 AU 2003213787A1
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
anorectal disorders
anorectal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003213787A
Other versions
AU2003213787A8 (en
Inventor
Stephen Grayson
Charles Lee
Jung-Chung Lee
Vivien H. W. Mak
Thomas P. Parks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DMK Pharmaceuticals Corp
Original Assignee
Cellegy Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellegy Pharmaceuticals Inc filed Critical Cellegy Pharmaceuticals Inc
Publication of AU2003213787A1 publication Critical patent/AU2003213787A1/en
Publication of AU2003213787A8 publication Critical patent/AU2003213787A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2003213787A 2002-03-06 2003-03-05 Compositions and methods for the treatment of anorectal disorders Abandoned AU2003213787A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36269802P 2002-03-06 2002-03-06
US60/362,698 2002-03-06
PCT/US2003/007106 WO2003075851A2 (en) 2002-03-06 2003-03-05 Compositions and methods for the treatment of anorectal disorders

Publications (2)

Publication Number Publication Date
AU2003213787A1 true AU2003213787A1 (en) 2003-09-22
AU2003213787A8 AU2003213787A8 (en) 2009-07-30

Family

ID=27805213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213787A Abandoned AU2003213787A1 (en) 2002-03-06 2003-03-05 Compositions and methods for the treatment of anorectal disorders

Country Status (2)

Country Link
AU (1) AU2003213787A1 (en)
WO (1) WO2003075851A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
ES2532906T5 (en) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Cosmetic and pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011039637A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
PL3261645T3 (en) 2015-02-27 2021-12-06 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
JP7530354B2 (en) 2018-06-01 2024-08-07 タバンタ セラピューティクス ハンガリー インコーポレイティド Topical amlodipine salts for the treatment of anorectal disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764921B2 (en) * 1998-12-14 2003-09-04 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders

Also Published As

Publication number Publication date
WO2003075851A3 (en) 2009-06-18
AU2003213787A8 (en) 2009-07-30
WO2003075851A2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
WO2003034984A9 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
AU2003286567A1 (en) Methods for the treatment of skin disorders
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
AU2003274342A1 (en) Compositions for the treatment of autoimmune disorders
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003238561A1 (en) Compositions and methods for treating gynaecological disorders
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AUPS017702A0 (en) Methods and compositions for the treatment of asthma and related disorders
AUPR101600A0 (en) Compositions and methods for diagnosis and treatment of cardiovascular disorders
AU2002363935A1 (en) Composition and method for the treatment of anorectal disorders
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
AUPS194902A0 (en) Compositions and methods for diagnosis and treatment of cardiovascular disorders
AU2002249983A1 (en) Compositions and methods for diagnosis of neuropsychiatric disorders
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
EP1539100A4 (en) Composition and methods for the treatment of skin disorders
AU2002363228A1 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
AU2003265281A1 (en) Methods and compositions for the enhancement of wound healing
WO2004096848A8 (en) Novel composition and methods for the treatment of immune disorders
EP1315499A4 (en) Compositions and methods for the treatment of anorectal disorders
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase